-
. These families may face uncertainty about when symptoms will develop and difficult decisions about treatment. Understanding their experiences and support needs is important for developing patient-centred screening
-
patients and families and learn about the priorities of affected communities. The position is based in Tübingen, Germany, with academic enrolment through the Eberhard Karls University of Tübingen. You will
-
test leading AAV capsids developed by Myrtelle Therapeutics Inc. in the in vitro model. You will assess their effects on myelination and oligodendrocyte survival. The most promising oligodendrocyte
-
, the University of Ghana, and Kenya Medicral Research Institute. Would you like to know more about the different phases within the PhD trajectory? You can read more about this on this page . The PhD student will
-
insights into coronary anatomy, blood flow, pressure, and wall shear stress—together with information about model uncertainty—the project aims to support more precise, physiology-guided treatment decisions